The double burden of diabetes and tuberculosis - Public health implications

Diabetes Research and Clinical Practice

Volumn 101, Issue 1, 2013, Pages 10-19

  Kapur, Anil ^a   Harries, Anthony D ^b,c  

^a World Diabetes Foundation   (Denmark)

^b INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Diabetes; Tuberculosis

Indexed keywords

GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; GLIPIZIDE; GLYCOSYLATED HEMOGLOBIN; ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

BODY MASS; CLINICAL FEATURE; COMORBIDITY; DIABETES CONTROL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG TREATMENT FAILURE; FINANCIAL MANAGEMENT; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH PROGRAM; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INFECTION RISK; INSULIN RESISTANCE; INSURANCE; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PREVALENCE; PUBLIC HEALTH PROBLEM; RECURRENT DISEASE; REVIEW; SCREENING TEST; SPUTUM SMEAR; TUBERCULOSIS; TUBERCULOSIS CONTROL; PROGNOSIS; PUBLIC HEALTH;

DIABETES MELLITUS; HUMANS; PROGNOSIS; PUBLIC HEALTH; TUBERCULOSIS;

EID: 84879604687     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.12.001     Document Type: Review

References (70)

1. Dixon B. Diabetes and tuberculosis: an unhealthy partnership. Available from: infection.thelancet.com.
2. Gupta A., Shah A. Tuberculosis and diabetes: an appraisal. Ind J Tub 2000, 47:3.
3. Root H.F. The association of diabetes and tuberculosis. N Engl J Med 1934, 1:210.
4. Younger D., Hadley W.B. Joslin's diabetes mellitus 1971, 628-631. Lea and Febiger, Philadelphia. 11th ed. A. Marble, P. White, R.F. Bradley, L.P. Krall (Eds.).
5. Global Tuberculosis Report, 2012. Geneva: World Health Organization; 2012.
6. IDF. Atlas, 5th ed 2011.
7. Lönnroth K., Raviglione M. Global epidemiology of tuberculosis: prospects for control. Semin Respir Crit Care Med 2008, 29:481-491.
8. Kant L. Diabetes mellitus-tuberculosis: the brewing double trouble. Ind J Tub 2003, 5:183-184.
9. Jeon C.Y., Murray M.B. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008, 5:e152.
10. Stevenson C.R., Forouhi N.G., Roglic G., Williams B.G., Lauer J.A., Dye C., et al. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health 2007, 7:234.
11. Stevenson C.R., Critchley J.A., Forouhi N.G., et al. Diabetes and the risk of tuberculosis: a neglected threat to public health. Chronic Illn 2007, 3:228-245.
12. Jeon C.Y., Harries A.D., Baker M.A., Hart J.E., Kapur A., Lönnroth K., et al. Bi-directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Health 2010, 15:1300-1314.
13. Vijay V., Satyavani K., Vigneswari A., Rajeswari R., Chinnasamy C., Rajan S., et al. Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PLoS ONE 2012, 7:e41367.
14. Balakrishnan S., Vijayan S., Nair S., Subramoniapillai J., Mrithyunjayan S., Wilson N., et al. High diabetes prevalence among tuberculosis cases in Kerala, India. PLoS ONE 2012, 7:e46502.
15. Restrepo B.I., Camerlin A.J., Rahbar M.H., Wang W., Restrepo M.A., et al. Cross-sectional assessment reveals high diabetes prevalence among newly diagnosed tuberculosis cases. Bull World Health Organ 2011, 89:352-359.
16. Gupta S., Shenoya V.P., Bairya I., Srinivasa H., Mukhopadhyaya C. Diabetes mellitus and HIV as co-morbidities in tuberculosis patients of rural south India. J Infect Public Health 2011, 4:140-144.
17. Faurholt-Jepsen D., Range N., PrayGod G., Jeremiah K., Faurholt-Jepsen M., Aabye M.G., et al. Diabetes is a risk factor for pulmonary tuberculosis: a case-control study from Mwanza, Tanzania. PLoS ONE 2011, 6(8):e24215.
18. Codlin A., Nadeem A., Lotia I., Khan F., Bhurgri A., Khan A., et al. Diabetes prediabetes and tuberculosis in an Asian mega-city - Karachi, Pakistan. Int J Tuberc Lung Dis 2012, 16:S338-S339.
19. Baker M.A., Lin H.H., Chang H.Y., Murray M.B. The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study. Clin Infect Dis 2012, 54:818-825.
20. Saiki O., Negoro S., Tsuyuguchi I., Yamamura Y. Depressed immunological defence mechanisms in mice with experimentally induced diabetes. Infect Immun 1980, 28:127-131.
21. Yamashiro S., Kawakami K., Uezu K., Kinjo T., Miyagi K., Nakamura K., et al. Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol 2005, 139:57-64.
22. Tsukaguchi K., Okamura H., Ikuno M., Kobayashi A., Fukuoka A., Takenaka H., et al. The relation between diabetes mellitus and IFN-gamma, IL-12 and IL-10 productions by CD4+ alpha beta T cells and monocytes in patients with pulmonary tuberculosis. Kekkaku 1997, 72:617-622.
23. Al-Attiyah R.J., Mustafa A.S. Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guerin (BCG)-vaccinated healthy subjects. Clin Exp Immunol 2009, 158:64-73.
24. Stalenhoef J.E., Alisjahbana B., Nelwan E.J., van der Ven-Jongekrijg, Ottenhoff T.H.M., van der Meer J.W.M., et al. The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis 2008, 27:97-103.
25. Martens G.W., Arikan M.C., Lee J., Ren F., Greiner D., Kornfeld H. Tuberculosis susceptibility of diabetic mice. Am J Respir Cell Mol Biol 2007, 37:518-524.
26. Restrepo B.I., Fisher-Hoch S.P., Pino P.A., Salinas A., Rahbar M.H., Mora F., et al. Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis 2008, 47:634-641.
27. Vallerskog T., Martens G.W., Kornfeld H. Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis. J Immunol 2010, 184:6275-6282.
28. Lonnroth K., Williams B.G., Cegielski P., Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol 2010, 39:149-155.
29. Leung C.C., Lam T.H., Chan W.M., Yew W.W., Ho K.S., Leung G., et al. Lower risk of tuberculosis in obesity. Arch Intern Med 2007, 167:1297-1304.
30. Leung C.C., Lam T.H., Chan W.M., Yew W.W., Ho K.S., Leung G.M., et al. Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 2008, 167:1486-1494.
31. Restrepo B.I., Fisher-Hoch S.P., Crespo J.G., Whitney E., Perez A., Smith B., et al. Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect 2007, 135:483-491.
32. Singla R., Khan N., Al-Sharif N., Ai-Sayegh M.O., Shaikh M.A., Osman M.M. Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis 2006, 10:74-79.
33. Guler M., Unsal E., Dursun B., Aydln O., Capan N. Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract 2007, 61:231-235.
34. Bashar M., Alcabes P., Rom W.N., Condos R. Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997. Chest 2001, 120:1514-1519.
35. Fisher-Hoch S.P., Whitney E., Mccormick J.B., Crespo G., Smith B., Rahbar M.H., et al. Type 2 diabetes and multidrug-resistant tuberculosis. Scand J Infect Dis 2008, 1-6. [iFirst article].
36. Gan S.G., Khinmar K.W., Chee C., Wang Y.T. Diabetes mellitus in tuberculosis patients at tuberculosis control unit of Singapore and its impact on clinical presentations. Int J Tuberc Lung Dis 2012, 16:S334.
37. Baker M.A., Harries A.D., Jeon C.Y., Hart J.E., Kapur A., Lönnroth K., et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med 2011, 9:81.
38. Faurholt-Jepsen D. Diabetes is a strong predictor of mortality during TB treatment. A prospective cohort study amongst TB patients from Mwanza, Tanzania. PhD Thesis, Faculty of Science, University of Copenhagen; 2012.
39. Gregg E.W., Gu Q., Cheng Y.J., Venkat Narayan K.M., Cowie C.C. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med 2007, 147:149-155.
40. Lee P.-H., Lin H.-C., Huang A., Chan P.-C., Wei S.-H., Chen C.-H., et al. Diabetes mellitus and risk of recurrent tuberculosis: a population based case control study. Int J Tuberc Lung Dis 2012, 16:S334-S335.
41. Jimenez-Corona M., Cruz-Hervert L., Garcia L., Delgado-Sanchez G., Ferreyra-Reyes L.D., Ferriera-Guerrero E.E., et al. Association of diabetes and tuberculosis: impact of outcomes and transmissibility to household contacts. Int J Tuberc Lung Dis 2012, 16:S335-S336.
42. Kapur A., Harries A.D., Lönnroth K., Bygbjerg I.C., Lefebvre P.L. Diabetes and tuberculosis - old associates posing a renewed public health challenge. Eur Endocrinol 2009, 10-12.
43. Park J.Y., Kim K.A., Park P.W., Park C.W., Shin J.G. Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazide. Clin Pharmacol Ther 2003, 74:334-340.
44. Mugusi F., Swai A.B., Alberti K.G., McLarty D.G. Increased prevalence of diabetes mellitus in patients with pulmonary tuberculosis in Tanzania. Tubercle 1990, 71:271-276.
45. India Tuberculosis-Diabetes Study Group. Screening of patients with tuberculosis for diabetes mellitus in India. Paper submitted for publication to TMIH.
46. Li L., Lin Y., Mi F., Tan S., Liang B., Guo C., et al. Screening of patients with tuberculosis for diabetes mellitus in China. Trop Med Int Health 2012, 17:1294-1301.
47. Ogbera O. Screening for diabetes mellitus in patients with TB in Lagos Nigeria. In: Paper presented at the 43rd world lung conference, November 14-17, 2012 Kuala Lumpur, Malaysia.
48. Surya Kirani K.R.L., Santha Kumari V., Lakshmi Kumari R. Co-existence of pulmonary tuberculosis and diabetes mellitus: some observations. Ind J Tub 1998, 45:47-48.
49. http://www.who.int/tb/publications/2011/en/index.html.
50. Harries A.D., Murray M.B., Jeon C.Y., Ottmani S.-E., Lonnroth K., Barreto M.L., et al. Defining the research agenda to reduce the joint burden of disease from diabetes mellitus and tuberculosis. Trop Med Int Health 2010, 15:659-663.
51. Yang W., Lu J., Weng J., Jia W., Ji L., Xiao J., et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010, 362:1090-1101.
52. Restrepo B.I. Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances. Clin Infect Dis 2007, 45:436-438.
53. World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications. Report of WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus 1999, World Health Organization, Geneva.
54. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diab Care 2009;32:1327-34.
55. Kishore B., Nagrath S.P., Mathur K.S., Hazra D.K., Agarwal B.D. Manifest, chemical and latent chemical diabetes in pulmonary tuberculosis. J Assoc Physicians India 1973, 21:875-881.
56. Goyal B.N., Nigam P., Dubey A.L., Joshi L.D., Saxena H.N. Study of diabetic status in pulmonary tuberculosis. J Diab Assoc India 1978, 18:191-197.
57. Singh M.M., Biswas S.K., Shah A. Impaired glucose tolerance in active pulmonary tuberculosis. Ind J Tub 1984, 31:118-121.
58. Oluboyo P.O., Erasmus R.T. The significance of glucose intolerance in pulmonary tuberculosis. Tubercle 1990, 71:135-138.
59. Harries A.D., Billo N., Kapur A. Links between diabetes mellitus and tuberculosis: should we integrate screening and care?. Trans R Soc Trop Med Hyg 2009, 103:1-2.
60. Vianna L.G., Gilbey S.G., Barnes N.C., Guy R.J., Gray B.J. Cough threshold to citric acid in diabetic patients with and without autonomic neuropathy. Thorax 1988, 43:569-571.
61. Behera D., Das S., Dash R.J., Jindal S.K. Cough reflex threshold in diabetes mellitus with and without autonomic neuropathy. Respiration 1995, 62:263-268.
62. Lin Y., Li L., Mi F., Du J., Dong Y., Li Z., et al. Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health 2012, 17:1302-1308.
63. India Diabetes Mellitus - Tuberculosis Study Group. Screening of patients with Diabetes Mellitus for Tuberculosis in India. Paper submitted for publication to TMIH.
64. Maher D. The power of health information - the use of cohort monitoring in managing patients with chronic non-communicable diseases. Trop Med Int Health 2012.
65. Kapur A. Economic analysis of diabetes care. Indian J Med Res 2007, 125:473-482.
66. Harries A.D., Jahn A., Zachariah R., Enarson D Adapting the DOTS framework for tuberculosis control to the management of non-communicable diseases in sub-Saharan Africa. PLoS Med 2008, 5:e124.
67. Harries A.D., Zachariah R., Kapur A., Jahn A., Enarson D. The vital signs of chronic disease management. Trans R Soc Trop Med Hyg 2009, 103:537-540.
68. Allain T.J., van Oosterhout J.J., Douglas G.P., Joukes S., Gadabu O.J., Darts C., et al. Applying lessons learnt from the 'DOTS' Tuberculosis Model to monitoring and evaluating persons with diabetes mellitus in Blantyre, Malawi. Trop Med Int Health 2011, 16:1077-1084.
69. Khader A., Farajallah L., Shahin Y., Hababeh M., Abu-Zayed I., Kochi A., et al. Cohort monitoring of persons with hypertension: an illustrative example from a primary health care clinic for Palestine refugees in Jordan. Trop Med Int Health 2012, 17:1163-1170.
70. Khader A., Farajallah L., Shahin Y., Hababeh M., Abu-Zayed I., Kochi A., et al. Cohort monitoring of persons with diabetes mellitus in a primary health care clinic for Palestine refugees in Jordan. Trop Med Int Health 2012, 17:1569-1576.